Cell lines | B lymphoid subtypes | TP53 statusa | IQS019 cytotoxic effect (referred to untreated cells) | |
---|---|---|---|---|
1 μM, 48 h | 5 μM, 48 h | |||
DOHH-2 | FL | wt | 26% | 100% |
WSU-NHL | FL | del/mut | 6% | 80% |
WSU-FSCCL | FL | wt | 26% | 77% |
SC-1 | FL | del/mut | 4% | 43% |
JEKO-1 | MCL | del/mut | 21% | 75% |
MAVER-1 | MCL | del/mut | 15% | 70% |
UPN-1 | MCL | del/mut | 14% | 66% |
HBL-2 | MCL | del/mut | 12% | 64% |
MINO | MCL | del/mut | 19% | 64% |
GRANTA-519 | MCL | wt | 26% | 63% |
Z-138 | MCL | wt | 18% | 62% |
JVM-2 | MCL | wt | 16% | 58% |
REC-1 | MCL | wt | 12% | 48% |
MEC-2 | CLL | del/mut | 12% | 51% |
JVM-13 | CLL | wt | 7% | 46% |
MEC-1 | CLL | wt | 9% | 33% |
SUDHL-16 | GCB-DLBCL | del/mut | 15% | 47% |
OCI-LY8 | GCB-DLBCL | del/mut | 2% | 29% |
SUDHL-8 | GCB-DLBCL | del/mut | 15% | 32% |
OCI-LY10 | ABC-DLBCL | wt | 3% | 47% |
U-2932 | ABC-DLBCL | del/mut | 15% | 51% |